Skip to main
  1. Stocks
  2. Docebo
  3. Forecast
DCBO

Docebo (DCBO) Stock Forecast & Price Target

Docebo (DCBO) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Docebo is viewed positively because it is consistently outgrowing a difficult L&D spending backdrop while taking enterprise share from incumbents, with 3Q26 revenue of $70.3mm rising 14.1% Y/Y and ARR reaching $261.5mm, up 11.0% Y/Y, or 13.4% excluding OEM, acquired ARR and FX effects. Its fundamentals are further strengthened by expanding customer quality, including 609 customers above $100k in ARR, a 24% Y/Y increase in consolidated ACV to $77.9k, and solid profitability with $16.7mm of adjusted EBITDA in 3Q26 and a 20.2% FY26 margin outlook. Management’s willingness to invest in healthcare and life sciences, plus channel expansion and new enterprise wins, supports a long runway for durable growth and margin expansion while still maintaining a balanced leverage profile after the $60mm special dividend.

Bears say

Docebo is viewed negatively because the bear case assumes it cannot efficiently cross-sell or upsell incremental modules to its existing customer base, limiting monetization of its platform and compressing growth opportunities. It also may fail to generate meaningful returns from international expansion, which would leave revenue growth below 10% and suggest the business is struggling to scale beyond its core North American customer base. Together, these assumptions point to weak operating leverage, limited expansion of average revenue per customer, and a valuation risk tied to slowing top-line momentum.

Docebo (DCBO) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Docebo and is not a guaranteed prediction by Public.com or investment advice.

Docebo (DCBO) Analyst Forecast & Price Prediction

Get the latest Docebo (DCBO) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Docebo (DCBO)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Docebo (DCBO) Forecast

Analysts have given Docebo (DCBO) a Buy based on their latest research and market trends.

According to 5 analysts, Docebo (DCBO) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Docebo (DCBO)


Docebo (DCBO) Analyst Forecast & Price Prediction

Get the latest Docebo (DCBO) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Docebo (DCBO)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover DCBO stock data and trends